1015 Capital Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$718 – 585
2026
Q2
$718 Hold
2
– – ﹤0.01% 509
2026
Q1
$501 Hold
2
– – ﹤0.01% 530
2025
Q4
$550 Buy
+2
New +$547 ﹤0.01% 543

Other funds holding WST

1015 Capital Partners's WST Position: Q3 2026 in Review

1015 Capital Partners sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 2 shares — an estimated $718 sold.

1015 Capital Partners first reported a position in WST in Q4 2025 and held it in 3 quarters. The position peaked at $718 in Q2 2026. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • 1015 Capital Partners reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • 1015 Capital Partners sold 2 West Pharmaceutical shares in Q3 2026, an estimated $718.
  • 1015 Capital Partners first reported a position in West Pharmaceutical in Q4 2025 and held it in 3 quarters.
  • 1015 Capital Partners's West Pharmaceutical position peaked at $718 in Q2 2026.
  • 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on 1015 Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.